<DOC>
	<DOCNO>NCT02254083</DOCNO>
	<brief_summary>Study assess tolerability intravenous infusion 0.5 1.0 mg ( actual 0.8 mg ) BIBT 986 BS per hour 32 hour well pharmacokinetics effect blood coagulation parameter</brief_summary>
	<brief_title>Tolerability Pharmacokinetics/-Dynamics BIBT 986 BS Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; = 18 &lt; = 55 year BMI &gt; = 18.5 &lt; = 29.9 kg/m2 Any finding medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Abnormal PT , TT , aPTT ( must within normal range one repeat test ) , thrombocytes &lt; 150000/Î¼l ( two repeat first test ) Evidence hematuria either macroscopically detectable microscopic urinalysis ( normal microscopic result one repeated test ) Evidence blood dyscrasia , hemorrhagic diathesis , severe thrombocytopenia , cerebrovascular hemorrhage , bleed tendency associate active ulceration overt bleed gastrointestinal , respiratory genitourinary tract disease condition hemorrhagic tendency ( e.g . cerebral aneurysm , dissect aorta , Central nervous system ( CNS ) trauma , retinopathy , nephrolithiasis ) Recent contemplate diagnostic therapeutic procedure potential uncontrollable bleeding ( e.g . spinal puncture , lumbar block anaesthesia , surgery CNS eye surgery result large open surface ) within 14 day drug administration clinical trial Occult blood 1 3 subsequent faecal sample collect prestudy examination Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , within 14 day prior administration trial Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 mL , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality Veins unsuited i.v . puncture administration prolong infusion either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>